DTC Advertising Blogs

07|30|26

Preparing for FDA’s Proposed DTC Broadcast Overhaul

A proposed FDA rule could significantly reshape the future of direct-to-consumer (DTC) pharmaceutical advertising, prompting life sciences brands to rethink how they reach and engage patients. In our latest point of view, Dave Leitner, EVP, Head of Media, explores the potential impact of the FDA’s proposal to eliminate the long-standing “adequate provision” standard for broadcast […]

10|02|25

Unpacking the FDA’s Double Standard

In her latest op-ed for MM+M, Susan Perlbachs, Chief Creative Officer, delivers a powerful reflection on the FDA’s recent wave of untitled and warning letters—and the broader implications for how pharma is scrutinized compared to other industries. Read more.